REVVITY INC (RVTY) Stock Fundamental Analysis
NYSE:RVTY - New York Stock Exchange, Inc. - US7140461093 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to RVTY. RVTY was compared to 56 industry peers in the Life Sciences Tools & Services industry. RVTY scores excellent on profitability, but there are some minor concerns on its financial health. RVTY has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
RVTY had positive earnings in the past year.
RVTY had a positive operating cash flow in the past year.
In the past 5 years RVTY has always been profitable.
Each year in the past 5 years RVTY had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 2.32%, RVTY is doing good in the industry, outperforming 75.00% of the companies in the same industry.
With a decent Return On Equity value of 3.75%, RVTY is doing good in the industry, outperforming 73.21% of the companies in the same industry.
RVTY has a Return On Invested Capital of 2.71%. This is in the better half of the industry: RVTY outperforms 62.50% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RVTY is significantly below the industry average of 13.15%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.32% | ||
| ROE | 3.75% | ||
| ROIC | 2.71% |
ROA(3y)3.77%
ROA(5y)5.35%
ROE(3y)6.68%
ROE(5y)10.55%
ROIC(3y)3.45%
ROIC(5y)6.13%
1.3 Margins
RVTY has a Profit Margin of 10.35%. This is in the better half of the industry: RVTY outperforms 78.57% of its industry peers.
In the last couple of years the Profit Margin of RVTY has grown nicely.
The Operating Margin of RVTY (14.50%) is better than 75.00% of its industry peers.
In the last couple of years the Operating Margin of RVTY has grown nicely.
The Gross Margin of RVTY (56.25%) is better than 69.64% of its industry peers.
In the last couple of years the Gross Margin of RVTY has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.5% | ||
| PM (TTM) | 10.35% | ||
| GM | 56.25% |
OM growth 3Y-24.12%
OM growth 5Y2.06%
PM growth 3Y-26.42%
PM growth 5Y4.45%
GM growth 3Y-4.25%
GM growth 5Y2.89%
2. Health
2.1 Basic Checks
RVTY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, RVTY has less shares outstanding
RVTY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RVTY has been reduced compared to a year ago.
2.2 Solvency
RVTY has an Altman-Z score of 2.59. This is not the best score and indicates that RVTY is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of RVTY (2.59) is better than 60.71% of its industry peers.
RVTY has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as RVTY would need 6.05 years to pay back of all of its debts.
RVTY has a better Debt to FCF ratio (6.05) than 62.50% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that RVTY is not too dependend on debt financing.
RVTY's Debt to Equity ratio of 0.41 is in line compared to the rest of the industry. RVTY outperforms 46.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 6.05 | ||
| Altman-Z | 2.59 |
ROIC/WACC0.28
WACC9.67%
2.3 Liquidity
A Current Ratio of 3.58 indicates that RVTY has no problem at all paying its short term obligations.
RVTY's Current ratio of 3.58 is in line compared to the rest of the industry. RVTY outperforms 55.36% of its industry peers.
A Quick Ratio of 2.99 indicates that RVTY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.99, RVTY is in line with its industry, outperforming 57.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.58 | ||
| Quick Ratio | 2.99 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.71% over the past year.
RVTY shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.63% yearly.
RVTY shows a small growth in Revenue. In the last year, the Revenue has grown by 1.62%.
Measured over the past years, RVTY shows a decrease in Revenue. The Revenue has been decreasing by -0.91% on average per year.
EPS 1Y (TTM)6.71%
EPS 3Y-24.58%
EPS 5Y3.63%
EPS Q2Q%3.06%
Revenue 1Y (TTM)1.62%
Revenue growth 3Y-10.38%
Revenue growth 5Y-0.91%
Sales Q2Q%2.25%
3.2 Future
The Earnings Per Share is expected to grow by 11.48% on average over the next years. This is quite good.
Based on estimates for the next years, RVTY will show a small growth in Revenue. The Revenue will grow by 5.31% on average per year.
EPS Next Y2.66%
EPS Next 2Y7.3%
EPS Next 3Y9.27%
EPS Next 5Y11.49%
Revenue Next Year3.49%
Revenue Next 2Y4.69%
Revenue Next 3Y5.29%
Revenue Next 5Y5.31%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.39, which indicates a rather expensive current valuation of RVTY.
Compared to the rest of the industry, the Price/Earnings ratio of RVTY indicates a rather cheap valuation: RVTY is cheaper than 83.93% of the companies listed in the same industry.
RVTY is valuated rather cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.94, RVTY is valued correctly.
85.71% of the companies in the same industry are more expensive than RVTY, based on the Price/Forward Earnings ratio.
RVTY is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.52, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.39 | ||
| Fwd PE | 16.94 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, RVTY is valued cheaper than 82.14% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, RVTY is valued cheaply inside the industry as 80.36% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.5 | ||
| EV/EBITDA | 16.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RVTY does not grow enough to justify the current Price/Earnings ratio.
RVTY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)7.28
PEG (5Y)5.34
EPS Next 2Y7.3%
EPS Next 3Y9.27%
5. Dividend
5.1 Amount
RVTY has a yearly dividend return of 0.27%, which is pretty low.
Compared to an average industry Dividend Yield of 0.50, RVTY pays a better dividend. On top of this RVTY pays more dividend than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, RVTY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.27% |
5.2 History
The dividend of RVTY has a limited annual growth rate of 0.31%.
RVTY has paid a dividend for at least 10 years, which is a reliable track record.
RVTY has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.31%
Div Incr Years0
Div Non Decr Years23
5.3 Sustainability
11.95% of the earnings are spent on dividend by RVTY. This is a low number and sustainable payout ratio.
The dividend of RVTY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP11.95%
EPS Next 2Y7.3%
EPS Next 3Y9.27%
95.58
+0.68 (+0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.31%
Inst Owner ChangeN/A
Ins Owners0.31%
Ins Owner Change13.19%
Market Cap11.27B
Analysts77.69
Price Target128.65 (34.6%)
Short Float %5.05%
Short Ratio5.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.27% |
Yearly Dividend0.28
Dividend Growth(5Y)0.31%
DP11.95%
Div Incr Years0
Div Non Decr Years23
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.92%
Min EPS beat(2)1.58%
Max EPS beat(2)4.25%
EPS beat(4)4
Avg EPS beat(4)5.98%
Min EPS beat(4)1.58%
Max EPS beat(4)11.44%
EPS beat(8)7
Avg EPS beat(8)3.66%
EPS beat(12)10
Avg EPS beat(12)3.25%
EPS beat(16)14
Avg EPS beat(16)7.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.6%
Min Revenue beat(2)-1.76%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-1.76%
Max Revenue beat(4)-1.33%
Revenue beat(8)1
Avg Revenue beat(8)-1.79%
Revenue beat(12)2
Avg Revenue beat(12)-2.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.19%
PT rev (1m)0.05%
PT rev (3m)-10.79%
EPS NQ rev (1m)0.09%
EPS NQ rev (3m)-7.12%
EPS NY rev (1m)0.06%
EPS NY rev (3m)-0.26%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.39 | ||
| Fwd PE | 16.94 | ||
| P/S | 4.07 | ||
| P/FCF | 21.5 | ||
| P/OCF | 18.5 | ||
| P/B | 1.48 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.24 |
EPS(TTM)4.93
EY5.16%
EPS(NY)5.64
Fwd EY5.9%
FCF(TTM)4.45
FCFY4.65%
OCF(TTM)5.17
OCFY5.4%
SpS23.5
BVpS64.79
TBVpS-12.27
PEG (NY)7.28
PEG (5Y)5.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.32% | ||
| ROE | 3.75% | ||
| ROCE | 3.43% | ||
| ROIC | 2.71% | ||
| ROICexc | 3% | ||
| ROICexgc | 21.26% | ||
| OM | 14.5% | ||
| PM (TTM) | 10.35% | ||
| GM | 56.25% | ||
| FCFM | 18.92% |
ROA(3y)3.77%
ROA(5y)5.35%
ROE(3y)6.68%
ROE(5y)10.55%
ROIC(3y)3.45%
ROIC(5y)6.13%
ROICexc(3y)3.75%
ROICexc(5y)6.55%
ROICexgc(3y)27.62%
ROICexgc(5y)43.67%
ROCE(3y)4.37%
ROCE(5y)7.76%
ROICexcg growth 3Y-28.81%
ROICexcg growth 5Y-3.08%
ROICexc growth 3Y-26.85%
ROICexc growth 5Y-10.99%
OM growth 3Y-24.12%
OM growth 5Y2.06%
PM growth 3Y-26.42%
PM growth 5Y4.45%
GM growth 3Y-4.25%
GM growth 5Y2.89%
F-Score8
Asset Turnover0.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 6.05 | ||
| Debt/EBITDA | 3.87 | ||
| Cap/Depr | 20.31% | ||
| Cap/Sales | 3.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.35% | ||
| Profit Quality | 182.86% | ||
| Current Ratio | 3.58 | ||
| Quick Ratio | 2.99 | ||
| Altman-Z | 2.59 |
F-Score8
WACC9.67%
ROIC/WACC0.28
Cap/Depr(3y)19.72%
Cap/Depr(5y)23.7%
Cap/Sales(3y)2.9%
Cap/Sales(5y)2.67%
Profit Quality(3y)102.05%
Profit Quality(5y)111.41%
High Growth Momentum
Growth
EPS 1Y (TTM)6.71%
EPS 3Y-24.58%
EPS 5Y3.63%
EPS Q2Q%3.06%
EPS Next Y2.66%
EPS Next 2Y7.3%
EPS Next 3Y9.27%
EPS Next 5Y11.49%
Revenue 1Y (TTM)1.62%
Revenue growth 3Y-10.38%
Revenue growth 5Y-0.91%
Sales Q2Q%2.25%
Revenue Next Year3.49%
Revenue Next 2Y4.69%
Revenue Next 3Y5.29%
Revenue Next 5Y5.31%
EBIT growth 1Y8.67%
EBIT growth 3Y-32%
EBIT growth 5Y1.13%
EBIT Next Year15%
EBIT Next 3Y10.11%
EBIT Next 5Y11.05%
FCF growth 1Y36.87%
FCF growth 3Y-25.52%
FCF growth 5Y13.93%
OCF growth 1Y32.35%
OCF growth 3Y-23.63%
OCF growth 5Y11.57%